Dyslipidemia Risk in Thyroid Cancer Patients: A Nationwide Population-Based Cohort Study

ObjectiveThyroid cancer (TC) prevalence has been rapidly increasing. While the relationship between thyroid hormones and lipids has been widely investigated, studies regarding dyslipidemia in patients with TC have been scarce and controversial. We aimed to investigate dyslipidemia risk after TC diag...

Full description

Bibliographic Details
Main Authors: Youhyun Song, Hye Sun Lee, Goeun Park, Sang-Wook Kang, Ji Won Lee
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.893461/full
_version_ 1818157102042972160
author Youhyun Song
Hye Sun Lee
Goeun Park
Sang-Wook Kang
Ji Won Lee
author_facet Youhyun Song
Hye Sun Lee
Goeun Park
Sang-Wook Kang
Ji Won Lee
author_sort Youhyun Song
collection DOAJ
description ObjectiveThyroid cancer (TC) prevalence has been rapidly increasing. While the relationship between thyroid hormones and lipids has been widely investigated, studies regarding dyslipidemia in patients with TC have been scarce and controversial. We aimed to investigate dyslipidemia risk after TC diagnosis compared to the general population without TC.MethodA population-based prospective study was conducted using data from the Korean National Health Insurance Service-National Sample Cohort Database 2.0 (NHIS-NSC DB 2.0), with health insurance claim data of 1,108,369 subjects between 2002 and 2015. The final study sample comprised 466,735 adult subjects without TC or dyslipidemia diagnoses before the index year, 2009. Bidirectional analyses were performed using prospective and retrospective concepts. In the prospective analysis, Kaplan-Meier estimates were calculated and log-rank tests and univariable and multivariable Cox regression analyses were performed to determine the relationship between TC and dyslipidemia. The retrospective analysis involved 1:5 nested case-control matching based on dyslipidemia status and conditional logistic regression analysis.ResultsNo significant difference in dyslipidemia incidence was observed between TC patients and the control group, in either the prospective matched (log-rank P = 0.483) or non-matched (log-rank P = 0.424) analyses, or the retrospective analysis (P = 0.3724). In the prospective analysis, 193 patients after TC diagnosis showed similar risk of developing dyslipidemia with the 466,542 controls during the median 7 years of follow-up (unadjusted hazard ratio [HR], 1.102; 95% confidence interval [CI], 0.878-1.383; adjusted HR, 0.932; 95% CI, 0.707-1.230). Multiple propensity score-adjusted models showed similar results, and 114 patients and 570 matched controls showed an HR of 0.818 (95% CI, 0.598-1.120). In the retrospective comparison of dyslipidemia risk in 170 patients and 277,864 controls, the odds ratio was 0.822 (95% CI, 0.534-1.266).ConclusionsDyslipidemia risk was not significantly different between patients with TC and the general population, in both prospective and retrospective analyses.
first_indexed 2024-12-11T15:08:51Z
format Article
id doaj.art-42c0f74807194b658a5cd57b6d372d00
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-12-11T15:08:51Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-42c0f74807194b658a5cd57b6d372d002022-12-22T01:00:49ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-06-011310.3389/fendo.2022.893461893461Dyslipidemia Risk in Thyroid Cancer Patients: A Nationwide Population-Based Cohort StudyYouhyun Song0Hye Sun Lee1Goeun Park2Sang-Wook Kang3Ji Won Lee4Department of Family Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South KoreaBiostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, South KoreaBiostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, South KoreaThyroid-Endocrine Surgery Division, Department of Surgery, Yonsei University College of Medicine, Seoul, South KoreaDepartment of Family Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South KoreaObjectiveThyroid cancer (TC) prevalence has been rapidly increasing. While the relationship between thyroid hormones and lipids has been widely investigated, studies regarding dyslipidemia in patients with TC have been scarce and controversial. We aimed to investigate dyslipidemia risk after TC diagnosis compared to the general population without TC.MethodA population-based prospective study was conducted using data from the Korean National Health Insurance Service-National Sample Cohort Database 2.0 (NHIS-NSC DB 2.0), with health insurance claim data of 1,108,369 subjects between 2002 and 2015. The final study sample comprised 466,735 adult subjects without TC or dyslipidemia diagnoses before the index year, 2009. Bidirectional analyses were performed using prospective and retrospective concepts. In the prospective analysis, Kaplan-Meier estimates were calculated and log-rank tests and univariable and multivariable Cox regression analyses were performed to determine the relationship between TC and dyslipidemia. The retrospective analysis involved 1:5 nested case-control matching based on dyslipidemia status and conditional logistic regression analysis.ResultsNo significant difference in dyslipidemia incidence was observed between TC patients and the control group, in either the prospective matched (log-rank P = 0.483) or non-matched (log-rank P = 0.424) analyses, or the retrospective analysis (P = 0.3724). In the prospective analysis, 193 patients after TC diagnosis showed similar risk of developing dyslipidemia with the 466,542 controls during the median 7 years of follow-up (unadjusted hazard ratio [HR], 1.102; 95% confidence interval [CI], 0.878-1.383; adjusted HR, 0.932; 95% CI, 0.707-1.230). Multiple propensity score-adjusted models showed similar results, and 114 patients and 570 matched controls showed an HR of 0.818 (95% CI, 0.598-1.120). In the retrospective comparison of dyslipidemia risk in 170 patients and 277,864 controls, the odds ratio was 0.822 (95% CI, 0.534-1.266).ConclusionsDyslipidemia risk was not significantly different between patients with TC and the general population, in both prospective and retrospective analyses.https://www.frontiersin.org/articles/10.3389/fendo.2022.893461/fullthyroidthyroid cancerdyslipidemiahypercholesterolemialipids
spellingShingle Youhyun Song
Hye Sun Lee
Goeun Park
Sang-Wook Kang
Ji Won Lee
Dyslipidemia Risk in Thyroid Cancer Patients: A Nationwide Population-Based Cohort Study
Frontiers in Endocrinology
thyroid
thyroid cancer
dyslipidemia
hypercholesterolemia
lipids
title Dyslipidemia Risk in Thyroid Cancer Patients: A Nationwide Population-Based Cohort Study
title_full Dyslipidemia Risk in Thyroid Cancer Patients: A Nationwide Population-Based Cohort Study
title_fullStr Dyslipidemia Risk in Thyroid Cancer Patients: A Nationwide Population-Based Cohort Study
title_full_unstemmed Dyslipidemia Risk in Thyroid Cancer Patients: A Nationwide Population-Based Cohort Study
title_short Dyslipidemia Risk in Thyroid Cancer Patients: A Nationwide Population-Based Cohort Study
title_sort dyslipidemia risk in thyroid cancer patients a nationwide population based cohort study
topic thyroid
thyroid cancer
dyslipidemia
hypercholesterolemia
lipids
url https://www.frontiersin.org/articles/10.3389/fendo.2022.893461/full
work_keys_str_mv AT youhyunsong dyslipidemiariskinthyroidcancerpatientsanationwidepopulationbasedcohortstudy
AT hyesunlee dyslipidemiariskinthyroidcancerpatientsanationwidepopulationbasedcohortstudy
AT goeunpark dyslipidemiariskinthyroidcancerpatientsanationwidepopulationbasedcohortstudy
AT sangwookkang dyslipidemiariskinthyroidcancerpatientsanationwidepopulationbasedcohortstudy
AT jiwonlee dyslipidemiariskinthyroidcancerpatientsanationwidepopulationbasedcohortstudy